辅助生殖受孕儿童16年队列显示长期医疗利用更高
该研究基于澳大利亚儿童纵向研究,纳入4789名 singleton 儿童(246名经辅助生殖受孕),随访至16岁并链接医保记录。控制出生、妊娠及社会经济因素后,辅助生殖受孕儿童在2-3岁和4-5岁医疗费用更高,6-15岁ADHD药物和4-7岁心理健康药物处方几率显著增加。
要点
- 辅助生殖受孕儿童2-3岁和4-5岁医疗费用显著高于自然受孕儿童。
- 6-15岁辅助生殖受孕儿童ADHD药物处方几率增加2.41-3.20倍。
- 4-5岁和6-7岁心理健康药物处方几率分别增加5.24倍和2.96倍。
核心结论
- 辅助生殖受孕儿童长期医疗服务和资源需求更高,不能完全由社会经济相关父母就医行为或围产因素解释。
研究设计与样本
- 基于澳大利亚儿童纵向研究(Growing up in Australia: Longitudinal Study of Australian Children)的 population-based 纵向队列,链接澳大利亚 Medicare 行政记录。
- 纳入4789名单胎儿童,随访从出生至16岁,其中246名经辅助生殖受孕。
主要发现
- 控制出生、妊娠条件和社会经济特征后,2-3岁医疗费用平均差异为87.53美元(95%CI 8.87-166.19),4-5岁为117.53美元(95%CI 30.95-204.11)。
- 6-15岁辅助生殖受孕儿童ADHD药物处方几率比为2.41(95%CI 1.15-5.08)至3.20(95%CI 1.54-6.64)。
- 4-5岁和6-7岁心理健康药物处方几率比分别为5.24(95%CI 2.02-13.58)和2.96(95%CI 1.23-7.13)。
- 肾上腺素自动注射器、哮喘药物、湿疹药物、抗感染药物或其他药物处方差异很小或无差异。
临床怎么用
- 临床应关注辅助生殖受孕儿童长期医疗需求,考虑早期筛查和检测相关健康问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of medically assisted reproduction is increasing over time, and there are limited data on the long-term health services use associated with medically assisted reproduction. OBJECTIVE: This study aimed to examine the long-term healthcare service use and prescription medication use in children who were conceived through medically assisted reproduction and to compare it with that of naturally conceived children. STUDY DESIGN: Data from Growing up in Australia: Longitudinal Study of Australian Children, a population-based longitudinal cohort study, linked with Australian Medicare administrative records, were used for this study. Out-of-hospital healthcare service use and costs, including prescription medication use, were compared between children who conceived with and those who were conceived without medically assisted reproduction. Generalized linear models and logistic models were applied to investigate the association of medically assisted reproduction with total healthcare costs and the use of prescription medications with adjustment for a wide range of birth, pregnancy, and socioeconomic characteristics. RESULTS: The study included 4789 singleton children who were followed from birth to the age 16 years with 246 of them conceived through medically assisted reproduction. Higher healthcare use and costs were seen for children who were conceived through medically assisted reproduction when compared with naturally conceived children across all age bands, except for ages 10 to 11 years, and the differences were statistically significant for ages 2 to 3 years (mean difference, $87.53; 95% confidence interval, $8.87-$166.19) and for ages 4 to 5 years (mean difference, $117.53; 95% confidence interval, $30.95-$204.11) after controlling for birth, pregnancy conditions, and socioeconomic characteristics. Among all available age bands, children aged 6 to 15 years who were conceived through medically assisted reproduction were found to have 2.41 (95% confidence interval, 1.15-5.08) to 3.20 (95% confidence interval, 1.54-6.64) times the odds of being prescribed attention-deficit/hyperactivity disorder medications than naturally conceived children after controlling for birth, pregnancy, and socioeconomic characteristics. In terms of mental health medications, children who were conceived through medically assisted reproduction had 5.24 (95% confidence interval, 2.02-13.58) and 2.96 (95% confidence interval, 1.23-7.13) times the odds of being prescribed these medications than naturally conceived children for the age bands 4 to 5 and 6 to 7 years, respectively, after adjusting for covariates. Little to no differences were observed in the use of prescriptions for adrenaline autoinjectors, asthma medications, eczema medications, anti-infectives medications (antiviral, antibacterial, antifungal), or other medications between children conceived through medically assisted reproduction and those conceived naturally. CONCLUSION: This study highlights a higher need for long-term healthcare services and associated resources for children who were conceived through medically assisted reproduction, which cannot be explained by socioeconomic-related parental health-seeking behaviors and perinatal factors, like multiple births and birth weight. This study helps to anticipate the downstream financial impact on the health system associated with the increasing use of medically assisted reproduction and emphasizes an opportunity for early screening and detection of relevant health conditions among children conceived through medically assisted reproduction.
引用
- van Heusden A, Yuan W, Dalziel K, et al. Higher long-term healthcare utilization in children conceived through medically assisted reproduction: findings from a 16-year cohort study. Am J Obstet Gynecol. 2026. PMID: 41730488. doi:10.1016/j.ajog.2026.02.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。